Advanced company searchLink opens in new window

TEVA PHARMA HOLDINGS LIMITED

Company number 10119709

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Aug 2024 AA Full accounts made up to 31 December 2023
11 Apr 2024 CS01 Confirmation statement made on 11 April 2024 with updates
12 Mar 2024 SH19 Statement of capital on 12 March 2024
  • GBP 1
06 Mar 2024 SH20 Statement by Directors
06 Mar 2024 CAP-SS Solvency Statement dated 29/02/24
06 Mar 2024 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
07 Aug 2023 AA Full accounts made up to 31 December 2022
11 Apr 2023 CS01 Confirmation statement made on 11 April 2023 with no updates
26 Sep 2022 AA Full accounts made up to 31 December 2021
11 Apr 2022 CS01 Confirmation statement made on 11 April 2022 with no updates
03 Oct 2021 AA Full accounts made up to 31 December 2020
27 Apr 2021 CS01 Confirmation statement made on 11 April 2021 with no updates
15 Apr 2021 CH01 Director's details changed for Mr David Vrhovec on 1 October 2016
15 Apr 2021 CH01 Director's details changed for Mr David Vrhovec on 1 October 2016
09 Nov 2020 AA Full accounts made up to 31 December 2019
29 Apr 2020 TM01 Termination of appointment of Dean Michael Cooper as a director on 29 April 2020
29 Apr 2020 AP01 Appointment of Mr Stephen Michael Charlesworth as a director on 29 April 2020
28 Apr 2020 CS01 Confirmation statement made on 11 April 2020 with no updates
08 Oct 2019 AA Full accounts made up to 31 December 2018
30 Sep 2019 CH01 Director's details changed for Ms Kim Innes on 25 September 2019
15 Apr 2019 CS01 Confirmation statement made on 11 April 2019 with updates
02 Oct 2018 AA Full accounts made up to 31 December 2017
20 Jul 2018 TM01 Termination of appointment of Robert Williams as a director on 27 June 2018
13 Jul 2018 AP01 Appointment of Dean Michael Cooper as a director on 12 July 2018
16 Apr 2018 CS01 Confirmation statement made on 11 April 2018 with updates